Algemene informatie
MAASTRO clinic is een bestralingsinstituut dat de bestraling (radiotherapie) van diverse kankersoorten voor patienten in Limburg verzorgt.
Radiotherapie is een behandelingsvorm die gebruik maakt van straling. Radiotherapie wordt onder meer gebruikt bij de behandeling van kanker, maar ook andere (niet-kwaadaardige) aandoeningen komen soms voor een bestralingsbehandeling in aanmerking. Voor de bestraling wordt gebruik gemaakt van röntgenstraling die echter vele malen sterker is dan de straling die gebruikt wordt voor het maken van röntgenfoto's. Soms wordt ook een radioactieve bron gebruikt die in het lichaam in of dichtbij de tumor wordt aangebracht. Voor alle gebruikte straling geldt dat deze onzichtbaar, niet te ruiken en niet voelbaar is.
Radiotherapie is een behandelingsvorm die gebruik maakt van straling. Radiotherapie wordt onder meer gebruikt bij de behandeling van kanker, maar ook andere (niet-kwaadaardige) aandoeningen komen soms voor een bestralingsbehandeling in aanmerking. Voor de bestraling wordt gebruik gemaakt van röntgenstraling die echter vele malen sterker is dan de straling die gebruikt wordt voor het maken van röntgenfoto's. Soms wordt ook een radioactieve bron gebruikt die in het lichaam in of dichtbij de tumor wordt aangebracht. Voor alle gebruikte straling geldt dat deze onzichtbaar, niet te ruiken en niet voelbaar is.
Gerelateerde vragen
- Waar vind ik het jaarverslag van MAASTRO clinic?
- Wat is de rechtsvorm van MAASTRO clinic?
- Is MAASTRO clinic een afdeling van het academisch Ziekenhuis Maastricht?
- Kan ik onderzoek financieel ondersteunen? Kan ik donateur worden?
- Is MAASTRO clinic een commerciele organisatie?
- Is MAASTRO clinic ook met het openbaar vervoer bereikbaar?
- Kan ik een vergoeding krijgen voor eigen vervoer of taxivervoer naar MAASTRO clinic?
Gerelateerde publicaties
- Microscopic Disease Extension in Three Dimensions for Non-Small-Cell Lung Cancer: Development of a Prediction Model Using Pathology-Validated Positron Emission Tomography and Computed Tomography Features.
- Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer.
- Effectiveness of surgery and individualized high-dose hyperfractionated accelerated radiotherapy on survival in clinical stage I non-small cell lung cancer. A propensity score matched analysis
- The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer
- FDG for dose painting: a rational choice.
- Primary Ewing's sarcoma presenting as a Pancoast tumour.
- European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer.
- Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
- Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients.
- 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: An economic evaluation.
- Health-related quality of life in patients surviving non-small cell lung cancer.
- Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
- ESMO Guidelines Working Group. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer.
- Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: sequential perfusion-CT findings.
- Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.
- Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging.
- Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings.
- Information needs of early-stage prostate cancer patients: a comparison of nine countries.
- Dummy run and conformity indices in the ongoing EORTC Low Grade Glioma Trial 22033-26033: first evaluation of quality of radiotherapy planning
- Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice
- Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer
- CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer
- Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck.
- Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma.
- PORTEC Study Group. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trials
- A systematic methodology review of phase I radiation dose escalation trials.
- First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II.
- Establishment of a Radiogenomics Consortium.
- Synopsis of partial-body radiation diagnostic biomarkers and medical management of radiation injury workshop.
- The use of FDG-PET to target tumors by radiotherapy.
- Simulating demand for innovative radiotherapies: an illustrative model based on carbon ion and proton radiotherapy.
- 3D dose delivery verification using repeated cone-beam imaging and EPID dosimetry for stereotactic body radiotherapy of non-small cell lung cancer.
- Dose recalculation in megavoltage cone-beam CT for treatment evaluation: removal of cupping and truncation artefacts in scans of the thorax and abdomen.
- PET imaging of hypoxia using [(18)F]HX4: a phase I trial.
- Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications.
- The cost-effectiveness of particle therapy in non-small cell lung cancer: Exploring decision uncertainty and areas for future research.
- How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
- Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review.
- Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis.
- The influence of breast composition and interseed attenuation in dose calculations for post-implant assessment of permanent breast 103Pd seed implant.
- An algorithm for efficient metal artifact reduction in permanent seed implants.
- Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition
- Dosimetric evolution of the breast electron boost target using 3D ultrasound imaging
- Dosimetric consequences of misalignment and realignment in prostate 3DCRT using intramodality ultrasound image guidance
- Design of and technical challenges involved in a framework for multicentric radiotherapy treatment planning studies
- The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5.
- Diminished carcinogen detoxification is a novel mechanism for hypoxia inducible factor 1 (HIF-1) mediated genetic instability.
- COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion.
- Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinase.
- Level of activation of the unfolded protein response correlates with Paneth cell apoptosis in human small intestine exposed to ischemia- reperfusion.
- 18S is an appropriate housekeeping gene for in vitro hypoxia experiments.
- Re: Geme expression-based prognostic signatures in lung cancer: ready for clinical use?
- Carbonic anhydrase inhibitors: Gd(III) complexes of DOTA- and TETA-sulfonamide conjugates targeting the tumor associated carbonic anhydrase isozymes IX and XII.
- Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy.
- Carbonic anhydrase inhibitors: Gd(III) complexes of DOTA- and TETA-sulfonamide conjugates targeting the tumor associated carbonic anhydrase isozymes IX and XII.
- Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis.
- Radiotherapy for breast cancer: overview and new developments.
- Erythropoietin as an adjuvant treatment with (chemo) Radiation therapy for head and neck cancer: Up-dated systematic review with additional data and new methodology
- Impact of xerostomia and dysphagia on health-related quality of life in head and neck cancer patients
- Radiotherapy with photons, carbon-ions and protons in various head and neck cancers: a review and meta-analysis of observational studies
- PET scans in radiotherapy planning of lung cancer.
- Development and Validation of a Prognostic Model Using Blood Biomarker Information for Prediction of Survival of Non-Small-Cell Lung Cancer Patients Treated With Combined Chemotherapy and Radiation or Radiotherapy Alone (NCT00181519, NCT00573040, and NCT00572325).
- Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging.
- Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study.
- PET-based treatment response evaluation in rectal cancer: prediction and validation.
- Repeated PET-CT and perfusion-CT imaging in rectal cancer: FDG uptake corresponds with tumor perfusion
- Is there a role for radiation therapy in the management of adenoid cystic carcinoma of the breast?
- Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2x2 randomised controlled trial.
- An economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT.
- Forward Intensity-Modulated Radiotherapy Planning in Breast Cancer To Improve Dose Homogeneity: Feasibility of Class Solutions.
- Should Patient Setup in Lung Cancer Be Based on The Primary Tumor? An Analysis of Tumor Coverage and Normal Tissue Dose Using Repeated Positron Emission Tomography/Computed Tomography Imaging
- [(18)F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients.
- Systematic review and meta-analysis of radiotherapy in various head and neck cancers: Comparing photons, carbon-ions and protons.
- Volume or Position Changes of Primary Lung Tumor During (Chemo)Radiotherapy Cannot Be Used as a Surrogate for Mediastinal Lymph Node Changes: The Case for Optimal Mediastinal Lymph Node Imaging During Radiotherapy.
- The role of hypoxia inducible factor-1alpha in gynecological cancer.
- Technical Note: Cone beam CT imaging for 3D image guided brachytherapy for gynecological HDR brachytherapy
- Dosimetric consequences of misalignment and realignment in prostate 3DCRT using intramodality ultrasound image guidance
- Dosimetric evolution of the breast electron boost target using 3D ultrasound imaging
- Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients
- The effects of compensator and imaging geometry on the distribution of x-ray scatter in CBCT
- A CT based correction method for speed of sound aberration for ultrasound based image guided radiotherapy
- Simulation study on potential accuracy gains from dual energy CT tissue segmentation for low-energy brachytherapy Monte Carlo dose calculations
- Extracting atomic numbers and electron densities from a dual source dual energy CT scanner: Experiments and a simulation model
- The difference of scoring dose to water or tissues in Monte Carlo dose calculations for low energy brachytherapy photon sources
- Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study
- The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
- Predictors of volumetric growth and auditory deterioration in vestibular schwannomas followed in a wait and scan policy
- Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
- Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging
- Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: A prospective validation
- FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer
- Development of a multicomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy
- Treatment with curative intent of stage III non-small cell lung cancer patients of 75years: A prospective population-based study
- Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer
- Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancer
- Translational control is a major contributor to hypoxia induced gene expression
- Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials
- E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells
- Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons
- The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy
- miR-210 as a marker of chronic hypoxia, but not a therapeutic target in prostate cancer
- [(18)F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients
- Impact of Tumor Size and Tracer Uptake Heterogeneity in 18F-FDG PET and CT Non-Small Cell Lung Cancer Tumor Delineation
- Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients
- Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation
- Repeated positron emission tomography-computed tomography and perfusion-computed tomography imaging in rectal cancer: fluorodeoxyglucose uptake corresponds with tumor perfusion
- PET-based Treatment Response Evaluation in Rectal Cancer: Prediction and Validation
- Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours
- Volume or position changes of primary lung tumor during (chemo-)radiotherapy cannot be used as a surrogate for mediastinal lymph node changes: the case for optimal mediastinal lymph node imaging during radiotherapy
- Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study
Bestuurlijk Managementteam
| Naam : | Danny Vogten, MSc | |
| Functie : | Manager HR en Communicatie | |
| E-mail adres : | personeelszaken@maastro.nl |
| Naam : | dr. Geert Bosmans | |
| Functie : | Hoofd Fysica Innovatie | |
| E-mail adres : | afsprakenbureau@maastro.nl |
| Naam : | dr. ir. Andre Dekker | |
| Functie : | Klinisch fysicus | |
| E-mail adres : | afsprakenbureau@maastro.nl |
| Naam : | dr. Liesbeth Boersma | |
| Functie : | Hoofd patiëntenzorg | |
| E-mail adres : | afsprakenbureau@maastro.nl |
| Naam : | drs. Boy Vluggen, RA | |
| Functie : | Hoofd Business Control | |
| E-mail adres : | boy.vluggen@maastro.nl |
| Naam : | drs. Maria Jacobs | |
| Functie : | Lid Raad van Bestuur | |
| E-mail adres : | maria.jacobs@maastro.nl |
| Naam : | Huub Backes, MBA | |
| Functie : | Manager innovatie | |
| E-mail adres : | huub.backes@maastro.nl |
| Naam : | Mia Brouns, MLC | |
| Functie : | Hoofd patiëntenlogistiek | |
| E-mail adres : | mia.brouns@maastro.nl |
| Naam : | Prof.dr. Philippe Lambin | |
| Functie : | Voorzitter Raad van Bestuur, hoogleraar-directeur | |
| E-mail adres : | philippe.lambin@maastro.nl |